Articles

Conventional automated keratometry is better at measuring refractive outcomes after cataract surgery than pupil-based Scheimpflug keratometry.

Balancing risk in ophthalmic prescribing for wet AMD

Examining the role of SLT in the glaucoma treatment arsenal

Differences in nerve fibre layer (NFL) in the macular area can be easily detected using a modified optical coherence tomography (OCT) scanning technique.

Decreased tear levels of neuropeptide Y (NPY) and calcitonin gene?related peptide (CGRP) are linked to damaged tear function.

The spatial distribution and temporal profiles of corneal light scattering after corneal collagen crosslinking (CXL) are distinctive in keratoconus patients.

A combination of scleral buckling and vitrectomy produced better anatomical success rates and fewer operative procedures in surgery for primary retinal detachment patients.

Measuring ocular biometry in paediatric patients

Procedure using excimer laser, optimized prolate albation profile is a work in progress

Novel presbyopic treatment algorithm is part of the latest ablation planing software

ICR femto-incision technology simplifies surgery

The future of glaucoma medications and disease management

Diagnostic platform combines anterior surface topography, corneal tomography data

Better understanding the cornea pre- and post-refractive surgery

Intrastromal treatment optimal for patients with mild hyperopia, has strict indications

System's ability to induce flexibility in crystalline lens portends far-reaching effects on future

The best solution for minimizing induced ocular abberations after refractive surgery

As World Sight Day 2011 approaches we speak with Dr Gullapalli Nag Rao, founder of LV Prasad Eye Institute, on what it means, what has already been achieved and what we can do to continue to be part of the solution.

An investigation in the Journal of Cataract and Refractive Surgery strongly suggests the use of fortified antibiotic agents for prevention of vision loss in infectious keratitis patients.

Ner and intermediate vision improvement with a corneal impant

Macular oedema caused by both BRVO and CRVO responds to treatment

A round-up of the latest ophthalmic products

Rapid image acquisition and quantitative analysis are possible

Establishing the pattern of management of diffuse diabetic macular oedema in England

New ophthalmic company KalVista Pharmaceuticals has generated £8 million from series A contributed by Novo A/S and SV Life Sciences.

Abbott Medical Optics' Healon EndoCoat has received the European CE Mark of approval.

Luminous, a program created to develop the understanding of retinal vascular diseases, has enrolled its first patient this month.

Using a combination of observation and amblyopia therapy is successful in mild cases of periocular haemangioma of infancy (HOI).

The cytokine, pentoxifylline, is a safe and effective way to control tumor necrosis factor?a (TNF-a) in conjunctiva affected by ocular cicatricial pemphigoid (OCP).

Ciliary sulcus-to-sulcus (STS) diameter is most accurately measured using ultrasound biomicroscopy (UBM).